Drug Buyers, Generics Cos. Fight Over Bellwether Litigation

By Bryan Koenig · April 7, 2025, 7:59 PM EDT

Generic drug buyers vied Friday with the pharmaceutical companies they've accused of price-fixing over how to shape the first rounds of long-gestating Pennsylvania federal court litigation that the plaintiffs want heard...

To view the full article, register now.

Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Case Information

Case Title

IN RE: GENERIC PHARMACEUTICALS PRICING ANTITRUST LITIGATION

Case Number

Court

Pennsylvania Eastern

Nature of Suit

Other Statutes: Anti-Trust

Date Filed

August 05, 2016

Recent Articles By Bryan

April 08, 2025
Amedisys Gets Merger Filing Claim Paused In DOJ's UHG Suit
March 26, 2025
False COVID Cure Claims No Longer Feds' 'Current Priority'
March 20, 2025
Judge Won't Let Meijer Appeal Takeda's Arbitration Mandate
March 11, 2025
Trump Admin Drops Suit Over COVID Nasal Spray Ads Claims
March 03, 2025
Teva Should Face Key Copaxone Antitrust Claims, Court Told
March 03, 2025
Sutter Settles Years-Old Antitrust Suit On Courthouse Steps
February 25, 2025
FTC Probing $615M Healthcare Staffing Merger
February 24, 2025
PBMs To Challenge FTC Case At 8th Circ., But Without Pause
February 19, 2025
Judge Won't Halt PBM Case Over Attack On FTC Independence
February 14, 2025
FTC's Ferguson, PBMs Agree: Nix Leader Removal Safeguards